Quarterly report pursuant to Section 13 or 15(d)

EQUITY AND EARNINGS PER SHARE

v3.21.1
EQUITY AND EARNINGS PER SHARE
 3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
EQUITY AND EARNINGS PER SHARE EQUITY AND EARNINGS PER SHARE
 
A. Stock Options

The following is a summary of the changes in the Company’s outstanding options for the three months ended March 31, 2021:
Number of Options Weighted Average Strike Price Weighted Average Life Remaining (in years)
Balance at December 31, 2020 4,935,732  $ 2.57 
Exercised (1,048,652) 1.00 
Balance at March 31, 2021 3,887,080  $ 3.00  2.24
Exercisable at March 31, 2021 2,704,738  $ 3.13  2.34

As of March 31, 2021, the Company’s outstanding options were summarized as follows:
Number of Options
Held by the former Manager 2,578,593 
Issued to the former Manager and subsequently transferred to certain of the Manager’s employees (A) 1,308,154 
Issued to the independent directors 333 
Total 3,887,080 
Weighted average strike price $ 3.00 
(A)The Company and the former Manager agreed that options held by certain employees formerly employed by the Manager will not terminate or be forfeited as a result of the Termination and Cooperation Agreement, and the vesting of such options will relate to the relevant holder’s employment with the Company and its affiliates following January 1, 2018. In both February 2017 and April 2018, the former Manager issued 1,152,495 options to certain employees formerly employed by the Manager as part of their compensation. The options fully vest and are exercisable one year prior to the option expiration date, beginning March 2020 through January 2024. In 2019, a certain employee was terminated by the Company and 921,992 options reverted back to the former Manager.  The Company reversed $1.2 million in stock compensation expense related to these options. For the three months ending March 31, 2021, the former Manager exercised 1,048,652 options at a weighted average strike price of $1.00 resulting in common shares issued of 736,551.

Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the options. Stock-based compensation expense related to the employee options was $0.2 million during the three months ended March 31, 2021, and $(0.1) million during the three months ended March 31, 2020, respectively, and was recorded in general and administrative expense on the Consolidated Statements of Operations. The unrecognized stock-based compensation expense related to the unvested options was $0.9 million as of March 31, 2021 and will be expensed over a weighted average of 1.6 years.

B. Restricted Stock Units ("RSUs")

The following is a summary of the changes in the Company’s RSUs for the three months ended March 31, 2021.
Number of RSUs Weighted Average Grant Date Fair Value (per unit)
Balance at December 31, 2020 259,238  $ 3.72 
Vested / Released (12,538) $ 4.19 
Forfeited (11,777) $ 4.67 
Balance at March 31, 2021 234,923  $ 3.64 
The Company grants RSUs to the non-employee directors as part of their annual compensation. The RSUs are subject to a one year vesting period. During the three months ended March 31, 2021, the Company granted no RSUs to non-employee directors and 5,423 RSUs granted to non-employee directors vested. The Company also grants RSUs to employees as part of their annual compensation. The RSUs vest in equal annual installments on each of the first three anniversaries of the grant date. During the three months ended March 31, 2021, the Company granted no RSUs to employees and 7,115 RSUs granted to employees vested. Stock-based compensation expense is recognized on a straight-line basis through the vesting date of the RSUs. Stock-based compensation expense related to RSUs was $0.1 million during the three months ended March 31, 2021, and $0.3 million for the three months ended March 31, 2020. Stock-based compensation expense was recorded in general and administrative expense on the Consolidated Statements of Operations. The unrecognized stock-based compensation expense related to the unvested RSUs was $0.5 million as of March 31, 2021 and will be expensed over a weighted average of 1 year.

C. Dividends

No dividends were declared during the three months ended March 31, 2020 on the 9.750% Series B, 8.050% Series C or 8.375% Series D preferred stock, for the twelve-month period beginning February 1, 2020 and ending January 31, 2021. On March 12, 2021 the board of directors declared dividends on the Company’s preferred stock for the period beginning February 1, 2021 and ending April 30, 2021, payable on April 30, 2021 to holders of record of preferred stock on April 1, 2021, in an amount equal to $0.609375, $0.503125 and $0.523438 per share on the 9.750% Series B, 8.050% Series C and 8.375% Series D preferred stock, respectively. Dividends totaling $1.4 million were paid on April 29, 2021.

D. Earnings Per Share

The following table shows the Company's basic and diluted earnings per share (“EPS”):
Three Months Ended March 31,
2021 2020
Numerator for basic and diluted earnings per share:
   Loss from continuing operations after preferred dividends $ (12,299) $ (18,757)
   Loss Applicable to Common Stockholders $ (12,299) $ (18,757)
Denominator:
Denominator for basic earnings per share - weighted average shares 82,558,881  67,069,534 
Effect of dilutive securities
  Options —  — 
  RSUs —  — 
Denominator for diluted earnings per share - adjusted weighted average shares 82,558,881  67,069,534 
Basic earnings per share:
Loss from continuing operations per share of common stock after preferred dividends $ (0.15) $ (0.28)
Loss Applicable to Common Stock, per share $ (0.15) $ (0.28)
Diluted earnings per share:
Loss from continuing operations per share of common stock after preferred dividends $ (0.15) $ (0.28)
Loss Applicable to Common Stock, per share $ (0.15) $ (0.28)

The Company’s dilutive securities are outstanding stock options and RSUs. During the three months ended March 31, 2021, based on the treasury stock method, the Company had 881,911 outstanding stock options and RSUs, respectively, which were excluded due to the Company's loss position. During the three months ended March 31, 2020, based on the treasury stock method, the Company had 964,335 potentially dilutive securities.
On February 2, 2021, the Company completed the public offering of 23,285,553 shares of common stock and the sale of 672,780 shares of common stock to the Chairman of our Board of Director resulting in net proceeds to the Company of $54.6 million, after deducting the underwriters discount of $2.9 million. Other expenses related to the offering totaled $0.6 million. The Company intends to use all of the net proceeds from the offering to fund its 2021 Puttery expansion and for general corporate purposes.